Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of incomplete blinking as a measurement of dry eye disease.

The ocular surface·2019
Same author

Evaluation of preoperative anesthesia in patients with mediastinal tumors by cinematic rendering.

Journal of clinical anesthesia·2019
Same author

CRISPR/Cas9-mediated efficient genome editing via protoplast-based transformation in yeast-like fungus Aureobasidium pullulans.

Gene·2019
Same author

Mechanically Reinforced Catechol-Containing Hydrogels with Improved Tissue Gluing Performance.

Biomimetics (Basel, Switzerland)·2019
Same author

<sup>68</sup>Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to <sup>18</sup>F-FDG PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2019
Same author

Bortezomib-based chemotherapy reduces early mortality and improves outcomes in patients with ultra-high-risk light-chain amyloidosis: a retrospective case control study.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2019

Related Experiment Video

Updated: May 16, 2026

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells
08:21

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells

Published on: March 16, 2017

PTK7 marks the first human developmental EMT in vitro.

David N Chan1, Soheila F Azghadi, Jun Feng

  • 1Department of Molecular Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, United States of America.

Plos One
|December 5, 2012
PubMed
Summary

Human pluripotent stem cells model early developmental epithelial-to-mesenchymal transitions (EMTs). This study identifies PTK7 as a novel marker for purified EMT cells, revealing plasticity in human development.

More Related Videos

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos
08:50

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Published on: June 12, 2020

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

Related Experiment Videos

Last Updated: May 16, 2026

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells
08:21

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells

Published on: March 16, 2017

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos
08:50

Single Cell Collection of Trophoblast Cells in Peri-implantation Stage Human Embryos

Published on: June 12, 2020

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

Area of Science:

  • Developmental Biology
  • Stem Cell Biology
  • Human Embryogenesis

Background:

  • Epithelial-to-mesenchymal transitions (EMTs) are crucial for tissue diversity during fetal development.
  • Studying human in vivo EMTs at the molecular level is challenging.
  • Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) resemble epiblast cells preceding primitive streak formation.

Purpose of the Study:

  • To model the first human epithelial-to-mesenchymal transition (EMT) in vitro using pluripotent stem cells.
  • To investigate the molecular characteristics and plasticity of early human developmental EMTs.

Main Methods:

  • Generating embryoid bodies (EBs) from hESCs and hiPSCs.
  • Observing EMT events within 24-48 hours of EB formation.
  • Identifying and purifying PTK7-positive EMT populations.
  • Analyzing gene expression of EMT markers and extracellular matrix (ECM) proteins.
  • Assessing the plasticity of EMT cells through re-plating experiments.

Main Results:

  • Embryoid bodies derived from hESCs/hiPSCs exhibit a cascade of EMT events within 24-48 hours.
  • These EBs display hallmarks of developmental EMTs, primitive streak, and mesendoderm.
  • PTK7 is identified as a novel marker for this EMT population, enabling cell purification.
  • Gene expression analysis reveals upregulation of EMT markers and ECM proteins in PTK7+ cells.
  • Purified EMT cells retain developmental plasticity, reverting to an epithelial phenotype upon re-plating.

Conclusions:

  • Pluripotent stem cell-derived embryoid bodies provide a viable model for studying early human developmental EMTs in vitro.
  • PTK7 serves as a valuable marker for identifying and isolating human developmental EMT cells.
  • These findings offer insights into the molecular mechanisms and plasticity of human embryogenesis.